Displaying 1 - 12 of 16
Metabolism, Alcohol & Toxicity

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Tools for early detection of metabolic risk in MAFLD

Webcasts
View
Metabolism, Alcohol & Toxicity

Insights from the SIRIUS project – a population-wide liver disease screening program in Slovakia

Webcasts
View
Metabolism, Alcohol & Toxicity

Early screening of metabolic risk – the pharmacists’ perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

To what extent can HRQoL impact clinical outcomes in MAFLD?

Webcasts
View
Metabolism, Alcohol & Toxicity

Essential phospholipids in the liver health landscape – clinical evidence

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD – the importance of early identification and interventio

Webcasts
View
Displaying 1 - 12 of 16